Skip to main content
. 2018 May 30;8:8383. doi: 10.1038/s41598-018-26560-9

Figure 7.

Figure 7

Effect of anti-CLDN-5 ECR mAbs on the paracellular barrier of CLDN-5–expressing cells monolayer. Monolayers of MDCKII expressing mock (upper left), human CLDN-5 (upper right) or mouse CLDN-5 (lower left) were basolaterally treated with vehicle (PBS) or 135 µg/mL of antibodies (mouse IgG, 4F1 or 2B12) for 9 h. TEER was monitored throughout the treatment period. Relative TEER (%) to the value at 0 h is shown. Error bars represent standard error of the mean values (n = 3). *P < 0.05 versus vehicle treatment.